Back to Search Start Over

698 A phase 2 study of durvalumab combined with chemotherapy and stereotactic body radiotherapy (SBRT) in patients with oligometastatic non-small cell lung cancer (NSCLC) (SABRCURE trial)

Authors :
Ming Chen
Honglian Ma
Xianghui Du
Yujin Xu
Yongling Ji
Zhengbo Song
Source :
Regular and Young Investigator Award Abstracts.
Publication Year :
2022
Publisher :
BMJ Publishing Group Ltd, 2022.

Details

Database :
OpenAIRE
Journal :
Regular and Young Investigator Award Abstracts
Accession number :
edsair.doi...........b6e488f45a84c82a203d392a7cb64b78

Tools

Authors Abstract Subjects Details